BDAZ
Thanks for your insight.
If in fact the $16.3 bil estimate for the epigenetics market in 2022 does not include BET inhibitors then the estimate could be significantly understated. The key is to generate a revenue stream from one or several of these ~ 4,000 compounds.
Chicagoest